Tesla (TSLA) Q3 Earnings Reveal A Sharper Margin Squeeze

Tesla just reported Q3 2026 with earnings per share of US$0.24 and net income of US$787m, and the stock barely flinched. Shares slipped about 0.6% over the last session, a muted move for a business that usually swings hard on any hint of good or bad news.

The real story sits in profitability. Trailing net margin has compressed to 3.1% while the valuation still prices in a rich revenue multiple. That gap between a premium P/S and thinner profits turns today’s calm share price into a sentiment check on how much faith investors still place in Tesla’s long runway.

Like Tesla’s technology but uneasy about paying a premium P/S for a business with a 3.1% net margin? See how that trade off compares with our 27 high quality undervalued stocks.

Q3 2026 Earnings Summary

• Revenue (Q3 2026 vs. Q3 2025): US$28,046m vs. US$28,095m (broadly flat year over year)

• Net Income (Excl. Extra Items, Q3 2026 vs. Q3 2025): US$787m vs. US$1,373m (down 42.7% year over year)

• Basic EPS (Q3 2026 vs. Q3 2025): US$0.24 vs. US$0.43 (fell 42.9% year over year)

• Trailing 12-Month Net Profit Margin (Current vs. Prior Year): 3.1% vs. 5.3% (margin compressed over the last 12 months)

Tesla is pouring cash into robots, chips and Robotaxis. Ask Charlie what Tesla’s biggest swing bet is this cycle.

Tesla’s AI Ambition Shows First Concrete Revenue Milestones

For bullish investors, the key claim is that Tesla can turn its AI and robotics work into real, recurring service income layered on top of cars and batteries.

“Bullish analysts expect Tesla to turn its AI, autonomous mobility, and humanoid robotics efforts into recurring high margin software and service revenue streams that sit on top of existing vehicle and energy hardware sales.”

Q3 starts to put numbers behind that idea. Services and other margins reached a record 15.9%, helped by early Cybercab robotaxis and stronger supercharging and insurance economics. FSD, which now has over 1.7 million paying global users and a North American attach rate above 75%, is clearly moving from concept to paying software layer on Tesla’s installed vehicle base.

Not everyone reads the same price the same way. → See the higher figure this Narrative lands on, and how it gets there.

Tesla Capex Story: Discipline Or Delays?

Bearish investors argue Tesla’s heavy spend on robotaxis, Optimus and chips could drag on profitability if execution slips.

“Despite management committing to a very big capital investment phase that includes Optimus factories and in house chip production, the strain on free cash flow from capex that already exceeds US$25b per year and is guided to grow for 2 to 3 more years increases the chance that returns on this spending arrive later than expected and that interest expense and depreciation keep pressure on future net income.”

Q3 tells a mixed story. Capex guidance has been cut to about US$20b and free cash flow was positive at around US$1.5b, which eases the immediate cash strain. That said, management still describes a multi year, high spend buildout for Terafab and Optimus, and Terafab timelines now stretch toward 2028 and beyond. The lowered capex partly reflects slower than planned AI and robotics ramp, so the concern about delayed payoff is showing up in the numbers.

Hunt For Mispriced Earnings Power

Tesla’s quieter reaction to Q3 numbers shows how sharply sentiment can change around major earnings stories. The real opportunity is in stocks that could be undervalued before the market reassesses them.

• Company 1 – 42% below our estimate – builds solar tracking and control platforms that support storage and inverter expansion for project owners.

• Company 2 – 28% below our estimate – sells diagnostic and RF testing gear used by utilities, aerospace contractors and defense programs as infrastructure is upgraded.

• Company 3 – 45% below our estimate – runs a deposit-rich regional banking model that grows as a recent acquisition adds branches, loans and fee businesses.

That is three of the list. See the full list of 27 companies trading below our fair value estimates →

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include TSLA.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com